| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Circulation, Vol 72, 898-906, Copyright © 1985 by American Heart Association
S Nattel
Although overdoses of tricyclic antidepressant are known to produce both
sinus tachycardia and ventricular tachyarrhythmias in man, these have been
assumed to occur by independent mechanisms. This study was designed to
evaluate the relationship of ventricular activation frequency to the
cardiotoxic effects of amitriptyline. When amitriptyline was infused into
dogs with formalin-induced atrioventricular (AV) block to evaluate a broad
range of pacing frequencies, the drug produced dose-related QRS
prolongation that was markedly frequency dependent. Similar
frequency-dependent depression of the maximum rate of depolarization (Vmax)
was noted for canine Purkinje fibers superfused with amitriptyline in
vitro. The time constant of recovery from amitriptyline-induced block was
dose independent and averaged 228 msec in vivo and 216 msec in vitro. When
amitriptyline was infused into dogs with intact AV conduction, sinus
tachycardia occurred within 15 min, followed by progressive QRS
prolongation and ventricular tachyarrhythmias after an average 29 min.
Slowing of sinus rate by vagal stimulation (seven dogs) or intravenous
metoprolol (five dogs) reproducibly reversed the QRS prolongation and
ventricular tachyarrhythmias caused by amitriptyline. These studies show
that amitriptyline produces frequency-related depression of ventricular
conduction in vivo, with a time dependence similar to effects on the
maximum rate of depolarization in vitro. Interventions that slow heart rate
reverse the adverse effects of amitriptyline on ventricular conduction and
cardiac rhythm.
ARTICLES
Frequency-dependent effects of amitriptyline on ventricular conduction and cardiac rhythm in dogs
This article has been cited by other articles:
![]() |
C. Nau, M. Seaver, S.-Y. Wang, and G. K. Wang Block of Human Heart hH1 Sodium Channels by Amitriptyline J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 1015 - 1023. [Abstract] [Full Text] |
||||
![]() |
S. Nattel Experimental evidence for proarrhythmic mechanisms of antiarrhythmic drugs Cardiovasc Res, March 1, 1998; 37(3): 567 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Roden Risks and Benefits of Antiarrhythmic Therapy N. Engl. J. Med., September 22, 1994; 331(12): 785 - 791. [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1985 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |